BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/6/2019 8:31:40 AM | Browse: 839 | Download: 1065
 |
Received |
|
2019-02-22 03:09 |
|
Peer-Review Started |
|
2019-02-22 05:38 |
|
To Make the First Decision |
|
2019-03-27 03:40 |
|
Return for Revision |
|
2019-03-28 02:15 |
|
Revised |
|
2019-04-30 12:09 |
|
Second Decision |
|
2019-05-08 08:19 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-05-08 16:17 |
|
Articles in Press |
|
2019-05-08 16:17 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-05-17 16:20 |
|
Typeset the Manuscript |
|
2019-05-28 08:36 |
|
Publish the Manuscript Online |
|
2019-06-06 08:31 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Control Study |
| Article Title |
Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yi-Chen Chou, I-Ha Lao, Pei-Ling Hsieh, Ying-Ying Su, Chee-Wai Mak, Ding-Ping Sun, Ming-Jen Sheu, Hsing-Tao Kuo, Tzu-Ju Chen, Chung-Han Ho and Yu-Ting Kuo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yu-Ting Kuo, MD, PhD, Doctor, Department of Medical Imaging, Chi Mei Medical Center, 901 Chung-Hwa Road, Yung-Kang District, Tainan 710, Taiwan. ytkuorad@gmail.com |
| Key Words |
Tumor invasiveness; Gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid; Hepatobiliary; Contrast agent; Magnetic resonance imaging; Hepatocellular carcinoma |
| Core Tip |
Gadoxetic acid-enhanced-magnetic resonance imaging (EOB-MRI) has been shown to outperform other hepatocellular carcinoma (HCC) diagnostic tools. Our aim was to determine whether EOB-MRI findings could be used to predict pathologic stage T2 in patients with solitary HCC, clinical stage T1 (cT1). EOB-MRI was performed in 114 patients with solitary HCC [39 with pathologic stage T2 (pT2) and 75 with pT1]. Large tumor size, corona enhancement, and peritumoral hypointensity in hepatobiliary phase images were associated with high risk of pT2 HCC. The sensitivity of EOB MRI for detecting pT2 HCC was 86.2% when two or three of these MRI features were present. |
| Publish Date |
2019-06-06 08:31 |
| Citation |
Chou YC, Lao IH, Hsieh PL, Su YY, Mak CW, Sun DP, Sheu MJ, Kuo HT, Chen TJ, Ho CH, Kuo YT. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma. World J Gastroenterol 2019, 25(21): 2636-2649 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i21/2636.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i21.2636 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
